176 related articles for article (PubMed ID: 11451177)
21. A randomized, controlled study of thymosin-alpha1 therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B.
Zavaglia C; Severini R; Tinelli C; Franzone JS; Airoldi A; Tempini S; Bettale G; Ideo G
Dig Dis Sci; 2000 Apr; 45(4):690-6. PubMed ID: 10759236
[TBL] [Abstract][Full Text] [Related]
22. Maternal transmission risk and antibody levels against hepatitis B virus e antigen in pregnant women.
Lu LL; Chen BX; Wang J; Wang D; Ji Y; Yi HG; Chen T; Zhang Y; Petersen E; Li Q; Qu C
Int J Infect Dis; 2014 Nov; 28():41-4. PubMed ID: 25245000
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus vaccination for older adults.
Bennett RG; Powers DC; Remsburg RE; Scheve A; Clements ML
J Am Geriatr Soc; 1996 Jun; 44(6):699-703. PubMed ID: 8642163
[TBL] [Abstract][Full Text] [Related]
24. Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.
Couillin I; Pol S; Mancini M; Driss F; Bréchot C; Tiollais P; Michel ML
J Infect Dis; 1999 Jul; 180(1):15-26. PubMed ID: 10353856
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease.
Aziz A; Aziz S; Li DS; Murphy L; Leone N; Kennedy M; Dhillon S; Van Thiel DH
J Viral Hepat; 2006 Apr; 13(4):217-21. PubMed ID: 16611186
[TBL] [Abstract][Full Text] [Related]
26. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
[TBL] [Abstract][Full Text] [Related]
27. Failure of hepatitis B vaccination in patients receiving lamivudine prophylaxis after liver transplantation for chronic hepatitis B.
Lo CM; Liu CL; Chan SC; Lau GK; Fan ST
J Hepatol; 2005 Aug; 43(2):283-7. PubMed ID: 15964658
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic vaccination in chronic hepatitis B: preclinical studies in the woodchuck model.
Roggendorf M; Schulte I; Xu Y; Lu M
J Viral Hepat; 2007 Nov; 14 Suppl 1():51-7. PubMed ID: 17958643
[TBL] [Abstract][Full Text] [Related]
29. Induction or expansion of T-cell responses by a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Scott-Algara D; Pol S; Bréchot C; Michel ML
Hepatology; 2004 Oct; 40(4):874-82. PubMed ID: 15382173
[TBL] [Abstract][Full Text] [Related]
30. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
[TBL] [Abstract][Full Text] [Related]
31. The first five years of universal hepatitis B vaccination in South Africa: evidence for elimination of HBsAg carriage in under 5-year-olds.
Tsebe KV; Burnett RJ; Hlungwani NP; Sibara MM; Venter PA; Mphahlele MJ
Vaccine; 2001 Jul; 19(28-29):3919-26. PubMed ID: 11427266
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
[TBL] [Abstract][Full Text] [Related]
33. Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.
Whittle HC; Maine N; Pilkington J; Mendy M; Fortuin M; Bunn J; Allison L; Howard C; Hall A
Lancet; 1995 Apr; 345(8957):1089-92. PubMed ID: 7715343
[TBL] [Abstract][Full Text] [Related]
34. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
[TBL] [Abstract][Full Text] [Related]
36. Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
Wang Y; Chen T; Lu LL; Wang M; Wang D; Yao H; Fan C; Qi J; Zhang Y; Qu C
Vaccine; 2017 Feb; 35(7):1064-1070. PubMed ID: 28069363
[TBL] [Abstract][Full Text] [Related]
37. Impact of hepatitis B virus (HBV) preS/S genomic variability on HBV surface antigen and HBV DNA serum levels.
Pollicino T; Amaddeo G; Restuccia A; Raffa G; Alibrandi A; Cutroneo G; Favaloro A; Maimone S; Squadrito G; Raimondo G
Hepatology; 2012 Aug; 56(2):434-43. PubMed ID: 22271491
[TBL] [Abstract][Full Text] [Related]
38. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
[TBL] [Abstract][Full Text] [Related]
39. Relationship between serum hepatitis B virus DNA and surface antigen with covalently closed circular DNA in HBeAg-negative patients.
Lin LY; Wong VW; Zhou HJ; Chan HY; Gui HL; Guo SM; Wang H; Huang L; Bao SS; Xie Q; Chan HL
J Med Virol; 2010 Sep; 82(9):1494-500. PubMed ID: 20648602
[TBL] [Abstract][Full Text] [Related]
40. A pilot study on the combined therapy of granulocyte-macrophage colony-stimulating factor and hepatitis B vaccine on chronic hepatitis B virus carrier children.
Wang J; Zhu Q; Zhang T; Yu H
Chin Med J (Engl); 2002 Dec; 115(12):1824-8. PubMed ID: 12622932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
